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Abstract 
Purpose: In this study we aimed to report a comparative analysis between open and robotic nephron sparing sur-
geries (NSS) from a single institutional database.
Methods: Patients who have undergone NSS during the robotic era of our institution were included in this study. 
Open (n = 74) and robotic (n = 59) groups were compared regarding trifecta outcome. Trifecta was defined as; warm 
ischemia time (WIT) <25 min, negative surgical margins and the absence of perioperative complications.
Results: A total of 57 (77 %) and 45 (76 %) patients in the open and robotic groups, respectively achieved the trifecta 
outcome. Overall trifecta rate was 77 % (n = 102/133). The only statistically significant difference between trifecta 
positive and trifecta negative patients was the length of hospitalization (LOH). Except LOH; none of the tested param-
eters were shown to be predictive of trifecta outcome on univariate and multivariate analyses. Concerning trifecta 
positive patients; those in the open surgery group had larger tumors with a higher degree of morphometric complex-
ity and were hospitalized for a longer period of time. Additionally, operative duration was significantly higher in the 
robotic group.
Conclusions: In our cohort, no significant difference in achieving the trifecta outcome was reported after open and 
robotic NSS. Length of hospitalization was the only parameter that differed significantly between trifecta positive and 
trifecta negative patients. Surgical approach was not a significant predictor of simultaneous achievement of trifecta 
outcomes. Irrespective of the trifecta definition; larger and more complicated tumors were handled via open NSS.
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Background
The incidence of small renal masses has increased over 
the last decades due to the improvements and wide-
spread use of imaging techniques (Kane et  al. 2008). 
Nephron sparing surgery (NSS) is the gold standard 
treatment modality for cT1a renal tumors and it can be 
accomplished via open, laparoscopic and robot-assisted 
laparoscopic approaches. Moreover, whenever it is tech-
nically feasible, NSS has been advocated for the manage-
ment of larger (≤7  cm) renal tumors (Ljungberg et  al. 
2010; Motzer et al. 2009). Robotic NSS has gained con-
siderable popularity for the management of renal masses 
owing to its role in providing the advantages of minimally 
invasiveness while ensuring an easier transition from 
open surgery compared to pure laparoscopic surgery.
Trifecta has been adapted to describe the outcomes 
of patients undergoing robotic NSS. It’s initial definition 
that has been described by the University of Southern 
California Group includes negative surgical margins, no 
Open Access
*Correspondence:  oacar@kuh.ku.edu.tr 
1 Department of Urology, School of Medicine, Koc University, Istanbul, 
Turkey
Full list of author information is available at the end of the article
Page 2 of 7Acar et al. SpringerPlus  (2015) 4:472 
urologic complications, and a minimal decrease in renal 
function postoperatively. The same group reported that 
the range of patients achieving this outcome after robotic 
NSS was between 44 and 68 % (Hung et al. 2013; Khalifeh 
et al. 2013).
To compare open and robotic approaches, we herewith 
report a retrospective analysis of a single-surgeon series 
of ≤cT2a NSSs; evaluating clinical, surgical, pathologic, 
functional results and the simultaneous achievement of 
the trifecta outcomes.
Patients and methods
This study includes all 133 patients who underwent NSS 
after the introduction of robotic technology in our insti-
tution (as of May 2010). All surgical procedures were car-
ried out by a single surgeon (T.E.) who has accomplished 
a direct transition from open to robot-assisted surgery. 
Open (n =  74) and robotic (n =  59) groups were com-
pared regarding clinical (age, A.S.A. score, tumor diam-
eter, R.E.N.A.L. score, P.A.D.U.A. score and C-index), 
surgical (operative duration, estimated blood loss, length 
of hospitalization), functional (perioperative reduction 
in eGFR) results and trifecta outcome. Written informed 
consent was obtained from all patients prior to the retro-
spective chart review.
All patients demonstrated contrast-enhancing renal 
masses on preoperative computed tomography (CT) 
and/or magnetic resonance imaging (MRI). All treatment 
options were discussed thoroughly with the patients. 
Indications for NSS and technical details (open versus 
robotic NSS, off-clamp versus clamped NSS) were based 
on tumor characteristics (size, complexity, and location), 
patient comorbidities, and surgeon preference.
Tumor size was defined as the largest diameter of the 
tumor in cm. Based on preoperative radiologic findings, 
none of the patients had lymph node involvement or dis-
tant metastasis. Tumor morphometry was evaluated con-
jointly by two radiologists (M.V. and A.O. with 15-years 
and 4-years of experience in uroradiology, respectively) 
according to the R.E.N.A.L., P.A.D.U.A. and C-index 
methods (Kutikov and Uzzo 2009; Ficarra et  al. 2009; 
Simmons et  al. 2010). All surgical specimens were pro-
cessed according to the standard pathologic procedures 
by a single pathologist (Y.S.) with a 10-years of experi-
ence in uropathology. Pathological data included his-
tological subtype, T stage, Fuhrman grade and margin 
status. Tumor staging was designated according to the 
TNM classification based on the 2009 American Joint 
Committee on Cancer/International Union against Can-
cer Classification System.
All complications within 30 days of surgery were clas-
sified according to the modified Clavien system (Dindo 
et  al. 2004). Serum creatinine was measured 1  day, 
1 month, 3 months, and 6 months and then yearly after 
surgery. Estimated glomerular filtration rate (eGFR) was 
determined using the modified modification of diet in 
renal disease (MDRD) equation (Levey et al. 1999). Pre-
operative eGFR was compared to the eGFR on the last 
follow-up to assess long-term changes in renal function 
after NSS. Trifecta outcome was defined as a combina-
tion of warm ischemia time (WIT) <25 min, negative sur-
gical margins and no perioperative complications (Hung 
et al. 2013; Khalifeh et al. 2013).
Surgical technique
Open nephron-sparing surgery (ONSS) was performed 
using the intercostal (between 11th and 12th ribs) extra-
peritoneal flank approach, as previously described (Camp-
bell and Novick 1995). Briefly, after adequate exposure of 
the kidney, Gerota’s fascia was opened and perinephritic 
fatty tissue was dissected off the renal surface. Ureter and 
the vascular pedicle were marked with vessel loops. The 
decision about hilar clamping was given perioperatively 
according to in  situ findings and preoperative radiologic 
data. We did not implement cold-ischemia in any of these 
open NSSs. Tumors were removed via enucleoresection 
leaving a minimal margin of normal parenchyma (Kirkali 
and Canda 2008). Bleeding from the tumor bed was 
controlled with 3/0 polyglactin interrupted sutures and 
parenchyma was adapted with 2/0 monofilament running 
sutures, over a surgical bolster.
All robotic nephron-sparing surgeries (RNSS) were 
performed using the da Vinci Si surgical system (Intuitive 
Surgical, Inc., Sunnyvale, CA) with a 5-port approach, 
including two 8  mm ports for the robotic instruments, 
one 12  mm port for the robotic scope, and 2 ports for 
the bedside assistant. RNSS’s were carried out through 
the transperitoneal route with the patient in flank posi-
tion. After colonic mobilization, Gerota’s fascia was 
opened and tumor was adequately exposed. The deci-
sion to clamp renal pedicle was given during the opera-
tion, based on CT and/or MR images and intraoperative 
findings. If there was such a need, the renal artery was 
occluded with an external vessel loop secured with a 
hem-o-lok clip over a silicone tube (Rassweiler et  al. 
2000). After demarcating tumor margins with electro-
cautery, resection was carried out using cold-scissors. All 
tumors were enucleoresected leaving a minimal margin 
of normal parenchyma. Tumor bed was oversewn with 
3/0 polyglactin sutures (in case of pelvicalyceal violation) 
and parenchyma was approximated using the “sliding 
clip” technique (Benway et al. 2009).
Statistical analysis
All statistical analyses were two-sided and per-
formed using Statistics Toolbox within MATLAB (The 
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Mathworks Inc., Natick, MA). A Mann–Whitney rank-
sum test was utilized to determine statistically signifi-
cant parameter differences between the trifecta positive 
and trifecta negative patients, and between the trifecta 
positive patiens of the open and robotic NSS groups. The 
categorical variables were compared between robotic 
and open surgery subgroups with a Chi square test for 
proportions. The predictive factors for a positive trifecta 
outcome were identified by univariate and multivariate 
analyses using the Cox proportional hazards regression 
model. The differences were considered as statistically 
significant at a p value of <0.05.
Results
Clinical, surgical and functional results of all the open 
and robotic NSSs are summarized in Table 1. A total of 
57 (77 %) and 45 (76 %) patients in the open and robotic 
groups, respectively achieved the trifecta outcome and 
these values were not significantly different from each 
other. Overall trifecta rate was 77 % (n = 102/133). The 
reason for the failure to achieve trifecta was; the pres-
ence of complications (n = 15), surgical margin positivity 
(n = 1) and prolonged WIT (44 min) in addition to the 
presence of complications (n = 1) in the open NSS group. 
On the other hand, complications (n  =  9), prolonged 
WIT (n  =  3, mean value of 31.6  min), surgical margin 
positivity in addition to the presence of complications 
(n = 1) and prolonged WIT (36 min) in addition to the 
presence of complications (n = 1) constituted the causes 
of trifecta negativity in the robotic NSS group.
A total of 26 and 17 Clavien grade ≥2 complications 
were recorded in 16 and 11 patients in the open and 
robotic NSS groups, respectively. The distribution of the 
complication grades are listed in Table 1.
While analyzing the study group as a whole, the only 
statistically significant difference between trifecta posi-
tive and trifecta negative patients was the length of hos-
pitalization (LOH) (Table 2). Similarly, LOH was the only 
parameter that differed significantly between trifecta 
positive and trifecta negative patients, both in the open 
and in the robotic subgroups. On univariate and multi-
variate analyses, none of the parameters (including surgi-
cal approach) but only LOH was shown to be predictive 
of trifecta positivity in general (Table  3). The findings 
were the same after repeating the analyses in open sur-
gery (Table 4) and robotic surgery subgroups (Table 5).
Concerning the comparison between trifecta positive 
patients in the open and robotic groups (Table 6); those 
in the open surgery group had larger tumors with higher 
R.E.N.A.L. and P.A.D.U.A. scores and were hospitalized 
for a longer period of time. Additionally, operative dura-
tion was significantly higher in the robotic group when 
compared with that recorded in the open group.
The difference between trifecta positive and trifecta 
negative patients in terms of the reduction of eGFR at 
6-month follow-up was not statistically significant. Simi-
larly, when open and robotic groups were compared as a 
whole, the eGFR change from baseline was similar.
Discussion
Curing the cancer, saving the kidney and utilizing mini-
mally invasive approaches when technically feasible 
can be considered as the surgical priorities in the man-
agement of renal masses (Coffin et  al. 2011). However, 
Table 1 The differences between open and robotic NSS groups in terms of clinical, surgical and functional results
Italic values indicate statistical significance
Parameter Open (n = 74) Robotic (n = 59) p value
Mean patient age (years) 55.3 ± 11.2 51 ± 13.3 0.04
Gender (M/F) 48/26 46/13 0.0992
Mean A.S.A. score 1.6 ± 0.7 1.5 ± 0.6 0.4
Mean R.E.N.A.L. score 7.6 ± 1.9 6.1 ± 1.7 0.0001
Mean P.A.D.U.A. score 8.5 ± 1.7 7.3 ± 1.5 0.0001
Mean C-index value 1.3 ± 0.6 1.5 ± 0.4 0.1
Operated side (R/L) 32/42 25/34 0.9197
Mean operative duration (min) 101.01 ± 32.1 143.7 ± 46.5 0.0001
Mean estimated blood loss amount (ml) 187.2 ± 128.5 201.1 ± 223.4 0.6
Mean WIT (min) 7.6 ± 9.5 8.3 ± 11.4 0.72
Mean pathological tumor diameter (cm) 4.2 ± 2.02 3.4 ± 2.4 0.04
Mean length of hospitalization (days) 4.3 ± 1.7 3.8 ± 1.2 0.02
Mean preoperative eGFR (ml/min/1.73 m2) 85.02 ± 22.2 89.8 ± 16.6 0.1
Mean postoperative eGFR (ml/min/1.73 m2) 76.1 ± 20.9 83.8 ± 16.6 0.02
Mean perioperative reduction in eGFR (ml/min/1.73 m2) −8.90 ± 16.13 −6.01 ± 11.09 0.49
Complications, Clavien Grade: 2/3a/3b/4 (n) 15/5/5/1 13/2/2/0 0.5904
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postoperative complications are also of utmost impor-
tance since intraoperative and postoperative problems 
may necessitate additional interventions, prolonged hos-
pitalization, and may lead to morbidity and even mor-
tality (Laviana and Hu 2014). The term “trifecta”, which 
addresses the surgical margin status, duration of warm-
ischemia and the presence of complications, was intro-
duced in an effort to standardize the way of reporting 
NSS success and was initially used for robotic surgeries 
(Hung et al. 2013).
Khalifeh et al. reported a 31.6 % trifecta rate in a large 
single-surgeon pure laparoscopic NSS series and also 
noted that trifecta achievement is much more probable 
in robotic NSS (59 %) when compared to the pure lapa-
roscopic approach (Khalifeh et al. 2013). Their relatively 
low trifecta rate may be explained by; the technically 
demanding nature of the initial laparoscopic NSSs and 
the different inclusion criteria used. Hung et al. reported 
the trifecta achievement rate in a contemporary series 
consisting of NSSs for cT1 renal masses as 68  %. How-
ever, they defined trifecta as; negative surgical margin, 
minimal renal functional decrease and no urological 
complication (Hung et al. 2013).
On the other hand, in their recent matched-pair com-
parative analysis consisting of over 400 patients with 
clinical T1a renal masses, Minervini et  al. reported the 
trifecta rate as 78.6 and 74.3 % in open and laparoscopic 
NSS, respectively. Moreover, the surgical approach was 
not a significant predictor of a negative trifecta on multi-
variable analysis (Minervini et al. 2014). In our study, we 
Table 2 The differences between trifecta positive and trifecta negative NSSs (open and robotic) in terms of clinical, surgi-
cal and functional results
Italic value indicates statistical significance
All NSSs (n = 133) % trifecta = 0.77 Trifecta = 1 (n = 102) Trifecta = 0 (n = 31) p value
Mean patient age (years) 53.2 ± 12.7 53.8 ± 11.3 0.89
Mean A.S.A. Score 1.5 ± 0.6 1.6 ± 0.7 0.45
Mean R.E.N.A.L. score 6.9 ± 2.0 6.8 ± 1.9 0.75
Mean P.A.D.U.A. score 8.03 ± 1.7 8.0 ± 1.6 0.94
Mean C-index value 1.4 ± 0.6 1.3 ± 0.4 0.30
Mean pathological tumor diameter (cm) 3.8 ± 2.3 3.8 ± 1.7 0.48
Mean operative duration (min) 116.9 ± 41.03 129.8 ± 53.8 0.27
Mean estimated blood loss amount (ml) 169.2 ± 104.5 272.9 ± 302.5 0.11
Mean length of hospitalization (days) 3.7 ± 0.9 5.4 ± 2.1 1.2 × 10−6
Perioperative reduction in eGFR (ml/min/1.73m2) −7.68 ± 14.05 −7.40 ± 14.69 0.74
Table 3 Univariable and multivariable Cox analyses were performed to identify variables predictive of trifecta positive 
outcomes in the whole study population (including patients who have undergone open and robotic NSS)
Except length of hospital stay; none of the tested parameters were shown to be predictive of trifecta positivity
Italic values indicate statistical significance
Covariate Univariate analysis Multivariate analysis
Coefficient (bi) HR [exp(bi)] p value Coefficient (bi) HR [exp(bi)] p value
Surgical approach (open/robotic) 0.0076 1.0076 0.9654 0.1113 1.1177 0.6466
Mean patient age 0.0006 1.0006 0.9289 −0.0027 0.9973 0.7715
Gender −0.0747 0.9280 0.6949 −0.0164 0.9837 0.9377
Mean A.S.A. score 0.0419 1.0427 0.7440 −0.0814 0.9218 0.6446
Mean R.E.N.A.L. score −0.0068 0.9932 0.8753 −0.0515 0.9498 0.6174
Mean P.A.D.U.A. score −0.0018 0.9982 0.9721 −0.0055 0.9946 0.9608
Mean C-index value −0.0448 0.9562 0.7592 −0.1021 0.9030 0.6169
Mean operative duration 0.0013 1.0013 0.5238 −0.0017 0.9983 0.5065
Mean estimated blood loss amount 0.0009 1.0009 0.0846 0.0010 1.0010 0.1418
Mean WIT 0.0096 1.0097 0.2819 0.0145 1.0146 0.1510
Mean pathological tumor diameter −0.0019 0.9981 0.9593 0.0094 1.0095 0.8368
Mean length of hospitalization 0.1827 1.2005 0.0012 0.2259 1.2534 0.0013
Mean perioperative reduction in eGFR 0.0003 1.0003 0.9662 0.0039 1.0039 0.5733
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have found similar results and the rate of simultaneous 
achievement of the trifecta outcomes did not differ sig-
nificantly between open (77  %) and robotic (76  %) NSS 
groups. Likewise, surgical approach was not a significant 
predictor of trifecta positivity in our series.
The trifecta positivity rate in our cohort does not seem 
to be affected by the outcome of the robotic NSSs done 
in the early phase of the learning curve. The difference 
between the initial (between May 2010 and September 
2012) and latter (between September 2012 and Decem-
ber 2014) NSSs in terms of the trifecta achievement rate 
was statistically insignificant both in the open (88.4  % 
and 70.8 %, respectively) and robotic (83.3 % and 65.2 %, 
respectively) surgery groups. This can be the result of sur-
geon expertise level as proficient open surgeons require 
less knowledge for a successfull transition to robotic sur-
gery compared to novice open surgeons (Sood et al. 2015).
Despite the fact that the majority of perioperative com-
plications were of Clavien grade 2 both in the open and 
robotic NSS groups, their sole presence was the main 
factor underlying trifecta negativity in our cohort. Fur-
thermore, the distribution of complication severity was 
similar between the open and robotic NSS groups. A 
total of 7 patients (2 in the open NSS and 5 in the robotic 
Table 4 Univariable and multivariable Cox analyses were performed to identify variables predictive of trifecta positive 
outcomes in the open surgery group
Except length of hospital stay; none of the tested parameters were shown to be predictive of trifecta positivity
Italic values indicate statistical significance
Covariate Univariate analysis Multivariate analysis
Coefficient (bi) HR [exp(bi)] p value Coefficient (bi) HR [exp(bi)] p value
Mean patient age 0.0013 1.0013 0.8945 −0.0034 0.9966 0.8220
Gender −0.1152 0.8912 0.6362 −0.1928 0.8247 0.4899
Mean A.S.A. score 0.0449 1.0460 0.7834 −0.1564 0.8552 0.5204
Mean R.E.N.A.L. score −0.0068 0.9933 0.9122 −0.0808 0.9224 0.5453
Mean P.A.D.U.A. score 0.0117 1.0118 0.8617 0.0450 1.0460 0.7320
Mean C-index value −0.0777 0.9253 0.6480 −0.1456 0.8645 0.5655
Mean operative duration 0.0007 1.0007 0.8592 −0.0032 0.9968 0.4960
Mean estimated blood loss amount 0.0008 1.0008 0.3978 0.0009 1.0009 0.4700
Mean WIT 0.0085 1.0086 0.5145 0.0110 1.0111 0.4832
Mean pathological tumor diameter 0.0101 1.0102 0.8569 0.0165 1.0166 0.7815
Mean length of hospitalization 0.1641 1.1783 0.0169 0.2121 1.2363 0.0193
Mean perioperative reduction in eGFR 0.0017 1.0017 0.8187 0.0073 1.0074 0.4583
Table 5 Univariable and multivariable Cox analyses were performed to identify variables predictive of trifecta positive 
outcomes in the robotic surgery group
Except length of hospital stay; none of the tested parameters were shown to be predictive of trifecta positivity
Italic values indicate statistical significance
Covariate Univariate analysis Multivariate analysis
Coefficient (bi) HR [exp(bi)] p value Coefficient (bi) HR [exp(bi)] p value
Mean patient age 0.0001 1.0001 0.9923 −0.0002 0.9998 0.9904
Gender −0.0083 0.9917 0.9788 0.1756 1.1919 0.6369
Mean A.S.A. score 0.0385 1.0393 0.8531 0.0153 1.0154 0.9568
Mean R.E.N.A.L. score −0.0078 0.9923 0.9165 0.0151 1.0152 0.9356
Mean P.A.D.U.A. score −0.0218 0.9784 0.7997 −0.1063 0.8991 0.6374
Mean C-index value 0.0538 1.0553 0.8590 −0.1258 0.8818 0.7563
Mean operative duration 0.0022 1.0022 0.4514 −0.0025 0.9975 0.5106
Mean estimated blood loss amount 0.0010 1.0010 0.1246 0.0013 1.0013 0.1014
Mean WIT 0.0106 1.0107 0.3885 0.0174 1.0175 0.2279
Mean pathological tumor diameter −0.0110 0.9891 0.8304 0.0032 1.0032 0.9713
Mean length of hospitalization 0.3063 1.3584 0.0143 0.3830 1.4667 0.0132
Mean perioperative reduction in eGFR −0.0035 0.9965 0.7682 −0.0024 0.9976 0.8645
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NSS group) could not achieve trifecta due to the either 
surgical margin positivity and/or prolonged WIT.
Length of hospitalization, which is expected to be pro-
longed due to a complicated postoperative course, was 
the only parameter that showed a statistically significant 
difference between trifecta positive and trifecta nega-
tive patients. Moreover, LOH was shown to be the only 
parameter that can predict trifecta outcome in our study 
population. These findings are quite understandable since 
per definition that trifecta necessitates the absence of 
complications. Undoubtedly, if the absence of urologi-
cal complications is used as a criterion (Hung et al. 2013) 
instead of the virtual absence of any kind of complica-
tion, then the trifecta rate would have been higher in our 
series.
When open and robotic NSS groups were com-
pared without applying the trifecta criteria; patient age, 
R.E.N.A.L. score, P.A.D.U.A. score, excised tumor diam-
eter and length of hospitalization were found to be signif-
icantly higher in the open surgery group while operative 
duration being significantly longer in the robotic surgery 
group. Likewise, when the trifecta achievers in the open 
and robotic NSS groups were compared; the results were 
almost the same except for a statistically insignificant 
age difference. Nevertheless, the conclusion that can be 
drawn from this evaluation does not change, as patients 
with larger tumors with a more complicated morphomet-
ric profile, hence with an increased likelihood of periop-
erative complications, were managed via open NSS and 
inevitably they stayed in the hospital for a longer period 
of time than their robotic counterparts.
In the landmark study conducted by Thompson et al., 
the threshold WIT, above which the risk of postoperative 
acute kidney injury and de-novo stage 4 chronic kidney 
disease increases significantly, has been reported to be 
25 min (Thompson et al. 2010). However, this observation 
was based on the functional outcome of NSSs performed 
on solitary kidneys and subsequent studies documented 
that WIT should be limited to 20 min irrespective of the 
surgical approach (Thompson et  al. 2010; Nguyen and 
Gill 2008; Lane et al. 2013). In our series, less than 50 % 
of the patients in the robotic (45.9 %, n = 34) and open 
(37.2  %, n  =  22) NSS groups were managed with the 
mean WIT being 16.7 and 22.3 min, respectively. Those 
who have exceeded the limit of 25  min in our cohort 
(n  =  5) had a complicated tumor morphometry (mean 
R.E.N.A.L. score  =  7.2, mean P.A.D.U.A. score  =  8.6, 
mean C-index value = 1.3) and mean WIT in this small 
subgroup was 34.4 min (range = 26–44 min). Addition-
ally, the postoperative eGFR change at 6-month follow-
up was similar between open and robotic NSS groups.
A negative surgical margin does not guarentee a recur-
rence-free follow-up period and similarly the absence of 
urological complications, which has been used as a com-
ponent of trifecta in other series, may not mean anything 
for a patient who has been hospitalized longer due to a 
non-urological problem. Likewise, even a limited dura-
tion of warm-ischemia (<25  min) can lead to adverse 
functional outcomes, particularly if the indication for 
NSS is an absolute one (Thompson et al. 2010). Although 
the achievement of trifecta may be translated as an early 
indication of surgical success, long-term follow-up is 
needed to validate the actual value of these criteria. 
Therefore the ideal way of reporting success in NSS series 
may be in the form of pentafecta, which includes long-
term stability of preoperative renal function, recurrence-
free follow-up, and complication-free perioperative 
period in addition to trifecta (Krane and Hemal 2014).
The main drawback of our study is the retrospective 
study design with its inherent selection biases. A proper 
randomization between open and robotic NSS would 
have served better to confirm the superiority of one 
Table 6 The differences between trifecta positive patients in open and robotic NSS groups in terms of clinical, surgical 
and functional results
Italic values indicate statistical significance
Parameter Open (n = 57) Robotic (n = 45) p value
Mean patient age (years) 55.12 ± 11.59 50.98 ± 13.79 0.12
Mean A.S.A. score 1.58 ± 0.71 1.49 ± 0.63 0.59
Mean R.E.N.A.L. score 7.67 ± 1.91 6.13 ± 1.79 0.0001
Mean P.A.D.U.A. score 8.51 ± 1.74 7.42 ± 1.56 0.0015
Mean C-index value 1.43 ± 0.72 1.54 ± 0.43 0.22
Mean operative duration (min) 100.18 ± 31.40 138.20 ± 42.24 2.3 × 10−6
Mean estimated blood loss amount (ml) 172.54 ± 111.92 165.11 ± 95.57 0.69
Mean pathological tumor diameter (cm) 4.15 ± 2.07 3.50 ± 2.74 0.005
Mean length of hospitalization (days) 3.96 ± 1.02 3.44 ± 0.76 0.0003
Mean perioperative reduction in eGFR (ml/min/1.73 m2) −9.44 ± 15.84 −5.46 ± 11.16 0.22
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approach over the other. Moreover, renal function was 
evaluated with the MDRD formula and not the nuclear 
imaging studies which could have been a more accurate 
way of determining function in each renal unit.
Conclusions
In our cohort, the rate of simultaneous achievement 
of the trifecta outcomes was similar between open and 
robotic NSS groups. The presence of complications was 
the main reason for trifecta negativity. Except for the 
length of hospital stay, all of the tested parameters were 
comparable between trifecta positive and trifecta nega-
tive patients. Surgical approach was not a significant 
predictor of trifecta positivity. Irrespective of the trifecta 
definition; open NSS was associated with larger tumor 
size, more complicated tumor morphometry and longer 
length of hospital stay.
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